Immunologic and Survival Benefits of Combined Heart-liver Transplantation in Children

Transplantation. 2021 Sep 1;105(9):e107-e108. doi: 10.1097/TP.0000000000003810.

Authors

Jondavid Menteer^{1

2}, Cameron Goldbeck^{2

3}, Cynthia Herrington^{1

2}, George Yanni^{2

4}, Juliet A Emamaullee^{2

3}

Affiliations

¹ Heart Institute, Children's Hospital Los Angeles, Los Angeles, CA.
² Keck School of Medicine, University of Southern California, Los Angeles, CA.
³ Division of Hepatobiliary and Abdominal Organ Transplant Surgery, University of Southern California, Los Angeles, CA.
⁴ Division of Gastroenterology and Hepatology, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, CA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Age Factors
Graft Survival
Heart Defects, Congenital / diagnosis
Heart Defects, Congenital / mortality
Heart Defects, Congenital / surgery*
Heart Transplantation* / adverse effects
Heart Transplantation* / mortality
Humans
Immunosuppressive Agents / therapeutic use
Liver Transplantation* / adverse effects
Liver Transplantation* / mortality
Registries
Risk Factors
Time Factors
Treatment Outcome
United States

Substances

Immunosuppressive Agents

Grants and funding

K08 CA245220/CA/NCI NIH HHS/United States